Bayer Schering Pharma Ag v. Lupin, Ltd.

Opinion

NOTE: ThiS order is nonprecedential United States Court of AppeaIs for the FederaI Circuit BAYER SCHERING PHARMA AG AND BAYER I'IEALTHCARE PHARMACEUTICALS, INC., Plaintiffs-Appellants, V. LUPIN, LTD AND LUPIN PHARMACEUTICALS, INC., Defen,dants-Appellees. . _ BAYER SCHERING PHARMA AG AND BAYER I'IEALTHCARE PHARMACEUTICALS, INC., Plc.-,intiffs-Appellants, V. SANDOZ, INC., Defendant-Appellee, AND WATSON PHARMACEUTICALS, INC. AND WATSON LABORATORIES, INC., Defend0:n,ts-Appellees. 2011-1143, -1228

BAYER SCHERING PHARMA V. LUPIN LTD 2 Appea1s from the United States District C0urt for the Southern District of New York in case nos 10-CV-5423 and 08-CV-371O, Judge Pa1L1 G. Gardephe. ON MOTION ORDER Lupin, Ltd. et a1. move without opposition for a 25-day extension of tin1e, until July 8, 2011, to file their brief Up0n consideration thereof IT ls 0RDEREo THAT: The motion is granted FOR THE CoUR_T -um 1 5 /s/ Jan Horba1y Date J an Horbaly C1erk cc: Peter V. Bensinger, Jr., Esq. HLED RObert F- Green, ESq~ u.s.coum oFA1>Pe\Ls ma J0Seph A_ HyndS, ESq_ THE FEDERAL C1RCU\T 1\/lark T. Jansen, Esq. JUN 1 Christopher N. Sipes, Esq. 5 2011 320 1mH0nsALv swan